#48 - Michael Oleksiw, CEO at Pleio

Join us on the latest episode! Our Guest: Michael Oleksiw, CEO at Pleio.What you'll get out of this episode:Human + AI Synergy: Pleio combines emotionally aware AI with peer-to-patient support to boost medication adherence.Overcoming Emotional Barriers: Emotions like fear, loneliness, and stigma are major challenges after diagnosis.Real-World Impact: Pleio's approach improved adherence rates by up to 28% in GLP-1 medication trials.Ethical AI in Healthcare: Patient data is de-identified and overseen by a medical board to ensure ethical use.Laser Focus on Loneliness: Pleio’s next frontier is tackling loneliness as a primary emotional barrier in healthcare.To Learn More About Our Guest And Their Company:Guest LinkedIn https://www.linkedin.com/in/michaeloleksiw/Company LinkedIn https://www.linkedin.com/company/pleio-inc/Website http://www.pleio.comOur sponsor for this episode are:Sage Growth Partners https://sage-growth.com/BioBreakthroughs is part of the Slice of Healthcare podcast network:LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/